Please ensure Javascript is enabled for purposes of website accessibility

Why Maxar Technologies, Amarin, and Revolve Group Jumped Today

By Dan Caplinger - Jul 2, 2019 at 4:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Favorable views of these companies helped lift their shares.

Tuesday was an up-and-down day on Wall Street as market participants watched major stock indexes trade on either side of the unchanged mark throughout the session, eventually finishing with modest gains. Favorable sentiment carried through from an eventful weekend on the geopolitical front, as goodwill developed from the G-20 summit made some investors more confident about the future. Yet the possibility for new tariffs on European goods suggested that trade tensions are far from over. Nevertheless, some companies were able to separate themselves from the crowd. Maxar Technologies (MAXR 5.54%), Amarin (AMRN 19.20%), and Revolve Group (RVLV 1.37%) were among the top performers. Here's why they did so well.

Is Maxar headed for a sale?

Shares of Maxar Technologies jumped 17% amid rampant speculation that the satellite company is looking to make a strategic divestiture. The provider of satellite imagery apparently has a couple of European companies looking at possibly bidding for Maxar's space systems business, with some reports suggesting that the unit could bring Maxar in excess of $1 billion. That's a big price tag for a company whose market capitalization is barely half that number, but even if an eventual bid is for less money, it could still help Maxar improve its balance sheet and put itself in position to continue its efforts to transform itself after a key satellite failure early this year.

Six-wheeled rover with solar panel and probes on a rocky surface under a blue sky with white clouds.

Image source: Maxar Technologies.

Amarin has a sunny outlook

Amarin's stock climbed 16% after the drug manufacturer issued a midyear update. The company boosted its sales guidance for full-year 2019 from $350 million to a new range of $380 million to $420 million. Demand for Amarin's Vascepa cardiovascular treatment has been strong, and the company believes that it's likely to be able to expand the current indications for the drug to make it a far larger commercial opportunity. CEO John Thero noted that he is "pleased with the progress made to date," especially with Vascepa, and Amarin hopes that it'll be able to sustain positive momentum for the rest of this year and beyond.

Revolve collects some endorsements

Finally, shares of Revolve Group gained 6%. The social-savvy online apparel company saw its post-IPO quiet period come to an end, freeing up stock analysts to weigh in. Out of nine new ratings on Revolve, eight came in at buy, with just a single hold among the crowd. The company's competitive advantage comes from its use of influence-rich promoters to drive demand for the products it sells, and so far, that seems to be going well. It'll be interesting to see whether actual results can live up to the hype that the IPO has generated, but for now, shareholders seem confident that Revolve will be able to pass the test and stay popular among investors.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amarin Corporation plc Stock Quote
Amarin Corporation plc
$1.49 (19.20%) $0.24
Maxar Technologies Stock Quote
Maxar Technologies
$29.17 (5.54%) $1.53
Revolve Group, Inc. Stock Quote
Revolve Group, Inc.
$29.59 (1.37%) $0.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.